Skip to main content
Clinical Trials/IRCT20200825048515N53
IRCT20200825048515N53RecruitingPhase 3

Evaluation of the effect of preemptive administration of two doses of dexmedetomidine in the prevention of chills, pain, nausea and vomiting after laparoscopic gallbladder surgery

Esfahan University of Medical Sciences0 sites75 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Patients candidates for laparoscopic cholecystectomy
  • American Anesthesiologists Association (ASA) Classification I and II
  • Age category 65-18 years
  • Satisfaction to participate in the study

Exclusion Criteria

  • History of monoamine oxidase inhibitor (MAOI), tricyclic antidepressant (TCA), vasoactive, analgesic, opioid before surgery

Investigators

Similar Trials